Ongoing studies into the drug are yielding promising results regarding body composition . Initially intended for treating diabetes , this GLP-1 receptor agonist has indicated impressive efficacy in https://travialist.com/story11879517/semaglutide-research-revealing-emerging-weight-loss-potential